Zhejiang CONBA Pharmaceutical Co Ltd (600572) — Free Cash Flow Generation Index
Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a Free Cash Flow Generation Index of 0.80x as of September 2025. Free cash flow of CN¥106.53 Million represents 1% of operating cash flow (CN¥133.43 Million). See 600572 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang CONBA Pharmaceutical Co Ltd Free Cash Flow Generation Index (2003–2025)
Historical FCF Generation Index trend for Zhejiang CONBA Pharmaceutical Co Ltd across 23 annual periods. Explore Zhejiang CONBA Pharmaceutical Co Ltd (600572) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2025)
Year-by-year Free Cash Flow Generation Index for Zhejiang CONBA Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Zhejiang CONBA Pharmaceutical Co Ltd stock valuation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.84x | CN¥795.35 Million | CN¥942.61 Million | CN¥147.26 Million | ▲ +18.3% |
| 2024 | 0.71x | CN¥721.90 Million | CN¥1.01 Billion | CN¥290.63 Million | ▼ -7.1% |
| 2023 | 0.77x | CN¥689.50 Million | CN¥898.64 Million | CN¥209.14 Million | ▲ +2.6% |
| 2022 | 0.75x | CN¥863.73 Million | CN¥1.16 Billion | CN¥291.75 Million | ▲ +106.9% |
| 2021 | 0.36x | CN¥321.56 Million | CN¥889.94 Million | CN¥568.37 Million | ▼ -42.8% |
| 2020 | 0.63x | CN¥789.30 Million | CN¥1.25 Billion | CN¥460.40 Million | ▼ -11.0% |
| 2019 | 0.71x | CN¥656.71 Million | CN¥925.50 Million | CN¥268.79 Million | ▲ +133.1% |
| 2018 | 0.30x | CN¥166.15 Million | CN¥545.78 Million | CN¥379.63 Million | ▼ -48.4% |
| 2017 | 0.59x | CN¥420.47 Million | CN¥712.27 Million | CN¥291.80 Million | ▼ -22.4% |
| 2016 | 0.76x | CN¥737.88 Million | CN¥969.71 Million | CN¥231.83 Million | ▲ +16.2% |
| 2015 | 0.65x | CN¥544.29 Million | CN¥831.26 Million | CN¥286.97 Million | ▲ +114.8% |
| 2014 | 0.30x | CN¥188.20 Million | CN¥617.43 Million | CN¥429.23 Million | ▲ +129.8% |
| 2013 | -1.02x | CN¥-240.97 Million | CN¥235.36 Million | CN¥476.32 Million | ▼ -4293.4% |
| 2012 | 0.02x | CN¥6.00 Million | CN¥245.76 Million | CN¥239.76 Million | ▼ -91.7% |
| 2011 | 0.29x | CN¥55.27 Million | CN¥188.36 Million | CN¥133.09 Million | ▲ +187.4% |
| 2010 | 0.10x | CN¥12.86 Million | CN¥125.93 Million | CN¥113.07 Million | ▼ -84.3% |
| 2009 | 0.65x | CN¥100.07 Million | CN¥153.39 Million | CN¥53.32 Million | ▲ +268.8% |
| 2008 | 0.18x | CN¥17.44 Million | CN¥98.56 Million | CN¥81.12 Million | ▲ +868.2% |
| 2007 | -0.02x | CN¥-1.84 Million | CN¥79.98 Million | CN¥81.83 Million | ▼ -129.7% |
| 2006 | 0.08x | CN¥5.53 Million | CN¥71.20 Million | CN¥65.67 Million | ▲ +748.3% |
| 2005 | 0.01x | CN¥1.08 Million | CN¥117.65 Million | CN¥116.57 Million | ▼ -64.0% |
| 2004 | 0.03x | CN¥1.66 Million | CN¥65.47 Million | CN¥63.81 Million | ▼ -93.6% |
| 2003 | 0.39x | CN¥26.30 Million | CN¥66.64 Million | CN¥40.34 Million | — |